Longitudinal Corneal Endothelial Cell Changes in Patients Undergoing Hematopoietic Stem Cell Transplantation

被引:7
|
作者
Pellegrini, Marco [1 ,2 ]
Giannaccare, Giuseppe [3 ]
Bernabei, Federico [1 ,2 ]
Moscardelli, Fabiana [1 ,2 ]
Sessa, Mariarosaria [2 ,4 ]
Arpinati, Mario [2 ,4 ]
Bonifazi, Francesca [1 ,2 ]
Versura, Piera [1 ,2 ]
机构
[1] Univ Bologna, Alma Mater Studiorum, Ophthalmol Unit, DIMES, Bologna, Italy
[2] S Orsola Malpighi Teaching Hosp, Bologna, Italy
[3] Magna Graecia Univ Catanzaro, Dept Ophthalmol, Catanzaro, Italy
[4] Univ Bologna, Hematol Unit, DIMES, Alma Mater Studiorum, Bologna, Italy
关键词
hematopoietic stem cell transplantation; ocular graft versus host disease; corneal endothelium; GVHD; dry eye; VERSUS-HOST-DISEASE;
D O I
10.1097/ICO.0000000000002441
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate longitudinally corneal endothelial cell changes in patients undergoing hematopoietic stem cell transplantation (HSCT) and to further investigate possible correlations with hematological and ocular characteristics. Methods: Prospective observational study conducted at a single center. All patients underwent a comprehensive ophthalmological examination, before and after HSCT, including slitlamp examination, Schirmer test, tear breakup time, ocular surface staining, specular microscopy of corneal endothelium, and Ocular Surface Disease Index questionnaire. Results: Twenty-five patients undergoing HSCT and 25 age- and sex-matched controls were included. At baseline, hematological patients showed significantly lower values of endothelial cell density (ECD) compared with those of controls (2514.5 +/- 390.2 vs. 2723.7 +/- 298.0 cells/mm(2), P = 0.038). After HSCT, ocular surface disease index score significantly increased (P = 0.020) and tear breakup time significantly decreased (P = 0.036). Conversely, no significant changes were found in Schirmer test and corneal fluorescein staining (always P > 0.05). Eight patients (32%) developed ocular graft-versus-host disease (GVHD). ECD values significantly decreased after HSCT (from 2514.5 +/- 390.2 to 2409.5 +/- 330.9 cells/mm(2), P = 0.009). The decrease in ECD values after HSCT was more pronounced in patients with ocular GVHD compared with those without (231.1 +/- 188.8 vs. 45.6 +/- 156.5, P = 0.016). No significant correlations between the changes in ECD and hematological and ocular characteristics were found (always P > 0.05). Conclusions: Hematological patients showed a lower endothelial cell count already before HSCT, compared with controls. After HSCT, the endothelial cell count further significantly decreased, particularly in patients who developed ocular GVHD.
引用
收藏
页码:462 / 466
页数:5
相关论文
共 50 条
  • [1] Longitudinal Analysis of Infrared Meibography in Patients Undergoing Hematopoietic Stem Cell Transplantation
    Bernabei, Federico
    Versura, Piera
    Pellegrini, Marco
    Moscardelli, Fabiana
    Bonifazi, Francesca
    Sessa, Mariarosaria
    Arpinati, Mario
    Scorcia, Vincenzo
    Giannaccare, Giuseppe
    CORNEA, 2020, 39 (07) : 812 - 817
  • [2] Telomere length changes in patients undergoing hematopoietic stem cell transplantation
    JJ Lee
    H Kook
    IJ Chung
    HJ Kim
    MR Park
    CJ Kim
    JA Nah
    TJ Hwang
    Bone Marrow Transplantation, 1999, 24 : 411 - 415
  • [3] Telomere length changes in patients undergoing hematopoietic stem cell transplantation
    Lee, JJ
    Kook, H
    Chung, IJ
    Kim, HJ
    Park, MR
    Kim, CJ
    Nah, JA
    Hwang, TJ
    BONE MARROW TRANSPLANTATION, 1999, 24 (04) : 411 - 415
  • [4] Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation
    Almici, C.
    Skert, C.
    Bruno, B.
    Bianchetti, A.
    Verardi, R.
    Di Palma, A.
    Neva, A.
    Braga, S.
    Piccinelli, G.
    Piovani, G.
    Malagola, M.
    Bernardi, S.
    Giaccone, L.
    Brunello, L.
    Festuccia, M.
    Baeten, K.
    Russo, D.
    Marini, M.
    BONE MARROW TRANSPLANTATION, 2017, 52 (12) : 1637 - 1642
  • [5] The Efficacy of an Oral Elemental Diet in Patients Undergoing Hematopoietic Stem Cell Transplantation
    Morishita, Takanobu
    Tsushita, Natsuko
    Imai, Kanae
    Sakai, Toshiyasu
    Miyao, Kotaro
    Sakemura, Reona
    Kato, Tomonori
    Niimi, Keiko
    Ono, Yoshitaka
    Sawa, Masashi
    INTERNAL MEDICINE, 2016, 55 (24) : 3561 - 3569
  • [6] Chemosensory changes and quality of life in patients undergoing hematopoietic stem cell transplantation
    Rania Abasaeed
    Susan E. Coldwell
    Michele E. Lloid
    Sohaib H. Soliman
    Paula C. Macris
    Mark M. Schubert
    Supportive Care in Cancer, 2018, 26 : 3553 - 3561
  • [7] Oral Changes in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Cohort Study
    Pereira, Tatiana Bernardo Farias
    Potter, Gleidston Silva
    Lima, Beatriz Maria Falcao
    Martins, Ana Rafaela Luz de Aquino
    Lopes, Maria Luiza Diniz de Sousa
    de Lima, Kenio Costa
    da Silveira, ericka Janine Dantas
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2025,
  • [8] Factors Influencing Changes in Quality of Life in Patients undergoing Hematopoietic Stem Cell Transplantation: A Longitudinal and Multilevel Analysis
    Song, Chi Eun
    So, Hyang Sook
    JOURNAL OF KOREAN ACADEMY OF NURSING, 2015, 45 (05) : 694 - 703
  • [9] Chemosensory changes and quality of life in patients undergoing hematopoietic stem cell transplantation
    Abasaeed, Rania
    Coldwell, Susan E.
    Lloid, Michele E.
    Soliman, Sohaib H.
    Macris, Paula C.
    Schubert, Mark M.
    SUPPORTIVE CARE IN CANCER, 2018, 26 (10) : 3553 - 3561
  • [10] Oral changes in individuals undergoing hematopoietic stem cell transplantation
    Barrach, Regina Haddad
    de Souza, Mair Pedro
    Camargo da Silva, Daniela Polo
    Lopez, Priscila Suman
    Montovani, Jair Cortez
    BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2015, 81 (02) : 141 - 147